X

Due to the lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

Updates regarding government operating status and resumption of normal operations can be found at http://www.usa.gov.
NIH Human Embryonic Stem Cell Registry - Research Using These Lines is Eligible for NIH Funding

NIH Human Embryonic Stem Cell Registry
Research Using This Line is Eligible for NIH Funding

Detailed information for selected cell line:

Cell Line: Lis26_FXS_6 (Fragile X)
NIH Registration Number: 0350
NIH Approval Number: NIHhESC-15-0350
Available for Distribution: Yes
Provider Restrictions: MTA and Tel Aviv Medical Center IRB amendment required

NIH Restrictions: NIH-funded research with this line is limited to research on Fragile X, consistent with the language from the informed consent document.

Additional Information: The embryo from which this hESC line was derived was affected with Fragile X

Submitting Organization: Tel Aviv Sourasky Medical Center
Provider Name: Dalit Ben-Yosef
Provider Phone:  
Provider Email: dalitb@tlvmc.gov.il
Provider URL: http://www.tasmc.org.il/sites/en/Research/Tech-Transfer/Pages/Stem-Cell-Research-laboratory.aspx
Approval Date: 07/16/2015


View All Lines Eligible for Use

Go to NIH Form 2890 Login Page

Go to NIH Stem Cell Information Page


   
Related Resources

    NIH Form 2890:

  • Login Page
    (Authorization Required)
    Contact Us:

  • Email questions to:
    hescregistry@mail.nih.gov

  • (Emails that are offensive or unrelated to stem cells will be deleted.)
 

This page last updated on July 13, 2011 
Content Manager: hescregistry@mail.nih.gov 
Technical Issues: E-mail OER Webmaster